Please use this identifier to cite or link to this item: https://bura.brunel.ac.uk/handle/2438/34209
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLau, Doreen-
dc.date.accessioned2026-11-20T09:33:49Z-
dc.date.available2026-11-20T09:33:49Z-
dc.date.issued2026-10-16-
dc.identifier.citationLau, D. (2026) 'Seeing the big picture: imaging in immunotherapy', Immunotherapy Advances, 6(1), ltag024, pp. 1–3. doi: 10.1093/immadv/ltag024.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/34209-
dc.descriptionData availability: Not applicable.en_US
dc.descriptionEditorial.en_US
dc.descriptionAcknowledgement: D.L. is a Working Group Co-Leader of the IMMUNO-model EU COST Action (CA21135), which focuses on modelling immunotherapy response and toxicity in cancer.en_US
dc.description.abstractImmunotherapies have transformed the treatment of cancer and are increasingly reshaping the management of autoimmune and infectious diseases. By modulating the immune system, these therapies have opened new opportunities to restore protective immunity and overcome immune dysfunction. Despite remarkable clinical successes, therapeutic responses remain highly variable, with many patients failing to respond or developing acquired resistance over time [1]. Understanding the dynamic interplay between immune cells, diseased tissues, and therapeutic interventions has therefore become one of the defining challenges in immunology. As the field continues to evolve, there is an increasing need for technologies that not only characterize immune phenotypes but also enable us to see the ‘big picture’ of when, where, and how immune responses develop, evolve, and determine therapeutic outcome. ...en_US
dc.description.sponsorshipNone declareden_US
dc.format.extentpp. 1–3-
dc.format.mediumElectronic-
dc.languageEnglish-
dc.language.isoenen_US
dc.publisherOxford University Press (OUP) on behalf of the British Society for Immunologyen_US
dc.rightsRe-use licence for this version: Creative Commons Attribution 4.0 International-
dc.rightsLicence for published version: Creative Commons Attribution 4.0 International-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectimmunotherapyen_US
dc.subjectmagnetic resonance imaging (MRI)en_US
dc.subjectmolecular imagingen_US
dc.subjectpositron emission tomography (PET)en_US
dc.subjecttheranosticsen_US
dc.titleSeeing the big picture: imaging in immunotherapyen_US
dc.typeArticleen_US
dc.date.dateAccepted2026-10-02-
dc.identifier.doihttps://doi.org/10.1093/immadv/ltag024-
dc.relation.isPartOfImmunotherapy Advances-
pubs.issue1-
pubs.publication-statusPublished-
pubs.volume6-
dc.identifier.eissn2732-4303-
dc.rights.licensehttps://creativecommons.org/licenses/by/4.0/legalcode.en-
dcterms.dateAccepted2026-10-02-
dcterms.issued2026-10-16-
dc.date.updated2026-11-10T12:07:50Z-
dc.rights.holderThe Author-
dc.contributor.orcidLau, Doreen [0000-0002-7623-2401]-
dc.identifier.numberltag024-
Appears in Collections:Department of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © The Author(s) 2026. Published by Oxford University Press on behalf of the British Society for Immunology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.185 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons